HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

AVDL

Avadel Pharmaceuticals plc

Last Close
Oct 15 • 04:00PM ET
13.20
Dollar change
+0.03
Percentage change
0.23 		%
Peers: JAZZ NBIX BMRN SUPN XENE AXSM VYGR PRTA KNSA NERV
 | Held by: VTI IWM IWO VTWO VTWG RSSL FYX GWX ONEQ FHLC
Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.15 Insider Own6.15% Shs Outstand96.27M Perf Week4.18%
Market Cap1.27B Forward P/E21.64 EPS next Y0.61 Insider Trans0.00% Shs Float90.35M Perf Month-4.42%
Income-106.22M PEG- EPS next Q-0.07 Inst Own71.47% Short Float12.14% Perf Quarter-18.87%
Sales95.15M P/S13.36 EPS this Y74.19% Inst Trans5.84% Short Ratio11.92 Perf Half Y-27.03%
Book/sh0.73 P/B18.07 EPS next Y218.16% ROA-59.26% Short Interest10.97M Perf Year25.48%
Cash/sh0.74 P/C17.80 EPS next 5Y15.00% ROE-99.52% 52W Range9.50 - 19.09 Perf YTD-6.52%
Dividend Est.- P/FCF- EPS past 5Y4.78% ROI-99.19% 52W High-30.85% Beta1.49
Dividend TTM- Quick Ratio2.52 Sales past 5Y-40.99% Gross Margin95.65% 52W Low38.95% ATR (14)0.50
Dividend Ex-Date- Current Ratio2.82 EPS Y/Y TTM44.80% Oper. Margin-103.82% RSI (14)46.13 Volatility3.72% 3.66%
Employees154 Debt/Eq0.54 Sales Y/Y TTM6260.23% Profit Margin-111.64% Recom1.00 Target Price24.18
Option/ShortYes / Yes LT Debt/Eq0.52 EPS Q/Q82.77% Payout- Rel Volume0.90 Prev Close13.17
Sales Surprise10.77% EPS Surprise21.74% Sales Q/Q2674.33% EarningsAug 08 BMO Avg Volume919.69K Price13.20
SMA201.57% SMA50-8.07% SMA200-13.92% Trades Volume824,506 Change0.23%
Date Action Analyst Rating Change Price Target Change
Jun-12-24Initiated Rodman & Renshaw Buy $27
Mar-05-24Reiterated Oppenheimer Outperform $27 → $29
Mar-05-24Reiterated Needham Buy $20 → $22
Mar-05-24Reiterated H.C. Wainwright Buy $21 → $25
Feb-06-24Initiated UBS Buy $21
Nov-30-22Upgrade Jefferies Hold → Buy $6.50 → $11
Aug-10-22Downgrade Jefferies Buy → Hold $6 → $8
Jul-28-22Resumed Craig Hallum Buy $15.50 → $12
May-26-22Downgrade Stifel Buy → Hold $9 → $2
Sep-23-21Initiated Needham Buy $17
Show Previous Ratings
Oct-09-24 05:36PM
Avadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
(GuruFocus.com)
Sep-25-24 08:00AM
Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent
(GlobeNewswire)
Sep-03-24 08:00AM
Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)
(GlobeNewswire)
Aug-28-24 08:00AM
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
(GlobeNewswire) -5.95%
Aug-27-24 08:46PM
Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer's Top Stock Picks For the Next 12 Months
(Insider Monkey)
08:00AM Loading…
Aug-20-24 08:00AM
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ (sodium oxybate) Extended-Release Oral Suspension
(GlobeNewswire)
Aug-08-24 07:13AM
Avadel: Q2 Earnings Snapshot
(Associated Press Finance)
07:00AM
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results
(GlobeNewswire)
Aug-06-24 04:06PM
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
(Investor's Business Daily)
Aug-05-24 09:55AM
Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?
(Zacks)
Aug-01-24 08:00AM
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8
(GlobeNewswire)
06:32AM
Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial
(Clinical Trials Arena)
Jul-31-24 04:05PM
Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ Trial of LUMRYZ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
(GlobeNewswire)
Jun-27-24 04:05PM
Avadel Pharmaceuticals to Join Russell 3000 Index
(GlobeNewswire)
May-30-24 08:00AM
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
(GlobeNewswire)
08:00AM Loading…
May-22-24 08:00AM
Avadel Pharmaceuticals Shares New LUMRYZ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
(GlobeNewswire)
May-21-24 07:00AM
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
(GlobeNewswire)
May-09-24 03:36PM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-08-24 11:55AM
AVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
(InvestorPlace) -10.62%
09:36AM
Avadel Pharmaceuticals Q1 Loss Narrows
(MT Newswires)
08:36AM
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...
(GuruFocus.com)
07:17AM
Avadel: Q1 Earnings Snapshot
(Associated Press Finance)
07:00AM
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
(GlobeNewswire)
May-01-24 08:00AM
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
(GlobeNewswire)
Apr-29-24 09:55AM
Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
(Zacks)
Apr-21-24 10:39AM
11 Best Low Price Pharma Stocks To Invest In
(Insider Monkey)
Apr-01-24 08:00AM
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
(GlobeNewswire)
Mar-05-24 10:25AM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript
(Insider Monkey)
08:00AM
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
(GlobeNewswire)
Mar-04-24 03:37PM
Avadel Pharmaceuticals Issues Statement On Patent Litigation
(GlobeNewswire) +17.57%
06:30AM Loading…
06:30AM
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Feb-26-24 08:00AM
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
(GlobeNewswire)
Feb-07-24 08:00AM
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
(GlobeNewswire)
Jan-18-24 10:35AM
Here's Why You Should Invest in Avadel (AVDL) Stock Now
(Zacks)
Jan-15-24 12:00PM
Avadel (AVDL) is a Great Momentum Stock: Should You Buy?
(Zacks)
09:55AM
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%
(Zacks)
Jan-12-24 08:32AM
Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick
(Zacks)
Jan-08-24 07:00AM
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
(GlobeNewswire) +8.42%
Nov-10-23 12:16PM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-08-23 07:07AM
Avadel: Q3 Earnings Snapshot
(Associated Press Finance) +11.90%
07:00AM
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Nov-07-23 08:00AM
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
(GlobeNewswire)
Oct-30-23 08:00AM
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8
(GlobeNewswire)
Oct-20-23 08:00AM
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023
(GlobeNewswire)
Oct-05-23 08:00AM
Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit
(GlobeNewswire) +7.88%
Sep-26-23 11:52AM
Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration
(GuruFocus.com)
Aug-31-23 10:16PM
12 Best High Risk High Reward Stocks To Buy Now
(Insider Monkey)
08:00AM
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
(GlobeNewswire)
Aug-13-23 08:09AM
Geoffrey Glass Bought 13% More Shares In Avadel Pharmaceuticals
(Simply Wall St.)
Aug-11-23 08:28AM
Investing in Avadel Pharmaceuticals (NASDAQ:AVDL) five years ago would have delivered you a 182% gain
(Simply Wall St.) +8.34%
07:01AM
Daily Vickers Top Buyers & Sellers for 08/11/2023
(Argus Research)
Aug-10-23 10:32PM
JANUS HENDERSON GROUP PLC Increases Stake in Avadel Pharmaceuticals PLC
(GuruFocus.com)
Aug-09-23 07:07AM
Avadel: Q2 Earnings Snapshot
(AP Finance)
07:00AM
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
Aug-03-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Aug-02-23 08:00AM
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
(GlobeNewswire)
Jul-28-23 02:56PM
10 Best Small Cap Pharma Stocks to Buy
(Insider Monkey)
Jul-20-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jul-06-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jul-03-23 04:50PM
Analysts Are Increasing Price Targets of These 10 Stocks
(Insider Monkey) -8.28%
Jun-23-23 09:57AM
Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'
(Benzinga) -11.41%
Jun-22-23 08:00AM
Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ (sodium oxybate) extended release for oral solution, CIII
(GlobeNewswire) +6.12%
Jun-20-23 10:10AM
Avadel Pharmaceuticals' Charts Are Pointed Higher
(TheStreet.com)
Jun-14-23 08:00AM
Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundations 2023 Young Investigators Research Forum
(GlobeNewswire)
Jun-13-23 08:00AM
Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy
(GlobeNewswire)
Jun-06-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jun-05-23 07:00AM
Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with Narcolepsy
(GlobeNewswire)
Jun-01-23 08:00AM
Avadel Pharmaceuticals to Present at the Jefferies Healthcare Conference
(GlobeNewswire)
May-31-23 04:00PM
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ at SLEEP 2023
(GlobeNewswire)
May-21-23 08:20AM
Independent Director of Avadel Pharmaceuticals Picks Up 8.4% More Stock \
(Simply Wall St.)
May-05-23 03:44PM
Why Shares of Avadel Soared This Week
(Motley Fool)
May-04-23 06:14PM
Avadel: Q1 Earnings Snapshot
(AP Finance)
04:05PM
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
(GlobeNewswire)
May-03-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +6.53%
07:24AM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Could Be 45% Below Their Intrinsic Value Estimate
(Simply Wall St.)
May-01-23 01:20PM
Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ (sodium oxybate) for Extended-Release Oral Suspension as the First and Only Once-at-Bedtime Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
(GlobeNewswire) +11.93%
Apr-20-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +6.78%
Apr-10-23 08:00AM
Avadel Pharmaceuticals to Present at the 22nd Annual Needham Healthcare Conference
(GlobeNewswire) +7.23%
Apr-05-23 07:44PM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2022 Earnings Call Transcript
(Insider Monkey)
Apr-03-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +5.24% -8.61%
Mar-30-23 07:00AM
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Mar-29-23 09:27PM
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 30
(GlobeNewswire)
09:24PM
Avadel Pharmaceuticals Announces Pricing of Public Offering of ADSs and Series B Preferred Shares
(GlobeNewswire)
04:13PM
Avadel Pharmaceuticals Announces Proposed Underwritten Public Offering of ADSs and Series B Preferred Shares
(GlobeNewswire)
04:01PM
Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million
(GlobeNewswire)
Mar-22-23 07:00AM
Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ Ahead of Anticipated Final Approval Decision
(GlobeNewswire) +7.85%
Mar-21-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Mar-02-23 07:00AM
Avadel Pharmaceuticals Requests Final FDA Approval for LUMRYZ (sodium oxybate) extended-release oral suspension
(GlobeNewswire)
Feb-28-23 10:37AM
Avadel Pharmaceuticals Shows Big Promise -- And Risk
(TheStreet.com)
Feb-24-23 04:16PM
UPDATE 2-Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
(Reuters) +7.74%
03:51PM
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
(Reuters)
Feb-16-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Feb-08-23 08:00AM
Avadel Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
(GlobeNewswire)
Feb-03-23 08:00AM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jan-24-23 08:00AM
Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates
(GlobeNewswire)
Jan-23-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jan-10-23 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Dec-19-22 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Dec-01-22 04:05PM
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +9.05% -7.20%
Nov-26-22 07:49AM
Avadel Pharmaceuticals plc (NASDAQ:AVDL) insiders placed bullish bets worth US$677k in the last 12 months
(Simply Wall St.)
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCHUGH THOMAS SChief Financial OfficerJan 16 '24Buy14.502,00029,00080,500Jan 16 04:36 PM
McCamish Mark AnthonyDirectorDec 28 '23Sale14.5375,0001,089,75067,025Dec 29 04:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.